U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

THIS PAGE IS TEMPORARILY UNDER CONSTRUCTION WHILE ENHANCEMENTS ARE UNDERWAY. Drug shortage data continues to be updated while under construction.

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Search Results

Carboplatin Injection
Status: Currently in Shortage
»Date first posted: 04/28/2023
»Therapeutic Categories: Oncology

Expand all

Accord Healthcare Inc. (Revised 02/05/2024)

Company Contact Information:
866-941-7875, option 2

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 10 mg/1 mL (NDC 16729-295-34) Manufacturing resumed, 30 days Inventory on hold pending further assessment. Requirements related to complying with good manufacturing practices
Injection, 10 mg/1 mL (NDC 16729-295-12) Manufacturing resumed, 30 days Inventory on hold pending further assessment. Requirements related to complying with good manufacturing practices

Eugia US LLC (Revised 01/24/2024)

Company Contact Information:
888-238-7880

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Carboplatin, Injection, 450 mg/45 mL (NDC 55150-335-01) Currently on backorder next shipment Jan Intermittent availability expected Demand increase for the drug
Carboplatin, Injection, 600 mg/60 mL (NDC 55150-386-01) Currently on backorder next shipment Jan Intermittent availability expected Demand increase for the drug

Fresenius Kabi USA, LLC (Revised 02/01/2024)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 10 mg/1 mL (NDC 63323-172-60) Available Check wholesaler for inventory

Gland Pharma Limited (Reverified 01/15/2024)

Company Contact Information:
Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 50mg/5mL (NDC 54288-164-01) Available Distributed by BPI Labs, LLC
Injection, 150mg/15mL (NDC 54288-165-01) Available Distributed by BPI Labs, LLC
Injection, 450mg/45mL (NDC 54288-166-01) Available Distributed by BPI Labs, LLC
Injection, 600 mg/65 mL (NDC 54288-167-01) Available Distributed by BPI Labs, LLC

Hospira, Inc., a Pfizer Company (Reverified 02/09/2024)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 10 mg/1 mL (NDC 61703-339-18) Limited Supply Available. Next Delivery and Estimated Recovery: March 2024

Pfizer Oncology Customer Letter (link)

Demand increase for the drug
Injection, 10 mg/1 mL (NDC 61703-360-18) Available
Injection, 10 mg/1 mL (NDC 61703-339-22) Limited Supply Available. Next Delivery: February 2024; Estimated Recovery: March 2024

Pfizer Oncology Customer Letter (link)

Demand increase for the drug
Injection, 10 mg/1 mL (NDC 61703-150-05) Limited Supply Available. Next Delivery: February 2024; Estimated Recovery: March 2024 Demand increase for the drug
Injection, 10 mg/1 mL (NDC 61703-339-50) Limited Supply Available. Next Delivery: February 2024; Estimated Recovery: March 2024

Pfizer Oncology Customer Letter (link)

Demand increase for the drug
Injection, 10 mg/1 mL (NDC 61703-262-05) Limited Supply Available. Next Delivery: February 2024; Estimated Recovery: March 2024 Demand increase for the drug
Injection, 10 mg/1 mL (NDC 61703-339-56) Limited Supply Available. Next Delivery: February 2024; Estimated Recovery: September 2024

Pfizer Oncology Customer Letter (link)

Demand increase for the drug
Injection, 10 mg/1 mL (NDC 61703-600-05) Limited Supply Available. Next Delivery: July 2024; Estimated Recovery: September 2024 Demand increase for the drug

Ingenus Pharmaceuticals LLC (Revised 12/22/2023)

Company Contact Information:
866-321-5031

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 600 mg/60 mL (NDC 50742-448-60) For any other information, please contact the Ingenus Customer Service team at 866-321-5031. Delay in shipping of the drug
Injection, 450 mg/45 mL (NDC 50742-447-45) Limited Availability For any other information, please contact the Ingenus Customer Service team at 866-321-5031. Delay in shipping of the drug

Teva Pharmaceuticals USA, Inc. (Revised 02/06/2024)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 10 mg/1 mL (NDC 0703-4239-01) Allocatng Existing Supplies, -
Injection, 10 mg/1 mL (NDC 0703-4244-01) Available
Injection, 10 mg/1 mL (NDC 0703-4246-01) Allocating Existing Supplies
Injection, 10 mg/1 mL (NDC 0703-4248-01) Unavailable, Recovery Estimated February TBD Demand increase for the drug

Teyro Labs (Revised 02/01/2024)

Company Contact Information:
800-706-5575 (Apotex Inc.)

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 10 mg/1 mL (NDC 60505-6282-1) Product is available Wholesaler & Distributor through Marketing partner (Apotex Inc.)
Injection, 10 mg/1 mL (NDC 60505-6282-3) Product is available Wholesaler & Distributor through Marketing partner (Apotex Inc.)
Injection, 10 mg/1 mL (NDC 60505-6282-6) Product is available Wholesaler & Distributor through Marketing partner (Apotex Inc.)
Back to Top